Abstract:Cancer phototheranostics in the second near-infrared window (NIR-II, 1000–1700 nm) has recently attracted much attention owing to its high efficacy and good safety compared with that in the first near-infrared window (NIR-I, 650–950 nm). However, the lack of theranostic nanoagents with active-targeting features limits its further application in cancer precision therapies. Herein, we constructed platelet-camouflaged nanoprobes with active-targeting characteristics for NIR-II cancer phototheranostics. The as-prepared biomimetic nanoprobes can not only escape phagocytosis by macrophages but also specifically bind to CD44 on the surface of most cancer cells. We evaluated the active-targeting performance of biomimetic nanoprobes in pancreatic cancer, breast cancer, and glioma mouse models and achieved NIR-II photoacoustic imaging with a high signal-to-background ratio and photothermal treatment with excellent tumor growth inhibition. Our results show the great potential of platelet-camouflaged nanoprobes with NIR-II active-targeting features for cancer precision diagnosis and efficient therapies.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c16872?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c16872</a>.Summary of probes for photoacoustic imaging combined with photothermal therapy under 1064 nm laser irradiation; zeta potential of LIPO-1048, BLIPO-1048, and PM; CD spectra of BLIPO-1048 and PM; relationship between the concentration of IR 1048 and the fluorescence intensity; standard curve of IR 1048 in 90% dimethyl sulfoxide solution; hydrodynamic diameters of BLIPO-1048 in H<sub>2</sub>O, PBS, and 10% FBS; drug release profiles of BLIPO-1048 in H<sub>2</sub>O, PBS, and 10% FBS; photothermal conversion efficiencies of IR 1048, LIPO-1048, and BLIPO-1048; photothermal stability of BLIPO-1048 and IR 1048; CLSM images of primary macrophages treated with LIPO-1048 and BLIPO-1048; flow cytometry analysis of RAW264.7 cells treated with LIPO-1048 and BLIPO-1048; flow cytometry analysis and fluorescence intensity of C6 cells treated with LIPO-1048 and BLIPO-1048; and hemolysis rate of BLIPO-1048 (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c16872/suppl_file/am0c16872_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Targeted Photoacoustic Imaging of Brain Tumor Mediated by Neutrophils Engineered with Lipid-Based Molecular Probe

Ultra-Small and Metabolizable Near-Infrared Au/Gd Nanoclusters for Targeted FL/MRI Imaging and Cancer Theranostics

Organic Small Molecule Contrast Agent for Targeted Photoacoustic Imaging of Patient‐Derived Brain Tumors

Targeted Imaging of Brain Tumors with a Framework Nucleic Acid Probe

Biomimetic Nanocomposites Cloaked with Bioorthogonally Labeled Glioblastoma Cell Membrane for Targeted Multimodal Imaging of Brain Tumors

Targeted Blue Nanoparticles As Photoacoustic Contrast Agent for Brain Tumor Delineation

Two-order Targeted Brain Tumor Imaging by Using an Optical/paramagnetic Nanoprobe Across the Blood Brain Barrier.

Photoacoustic imaging of tumor targeting with riboflavin-functionalized theranostic nanocarriers

Active-Targeting NIR-II Phototheranostics in Multiple Tumor Models Using Platelet-Camouflaged Nanoprobes

Delicately Designed Cancer Cell Membrane-Camouflaged Nanoparticles for Targeted 19 F MR/PA/FL Imaging-Guided Photothermal Therapy

A Bimodal MRI and NIR Liposome Nanoprobe for Tumor Targeted Molecular Imaging.

In Situ Fabrication of Nanoprobes for 19 F Magnetic Resonance and Photoacoustic Imaging-Guided Tumor Therapy

Photoacoustic Therapy for Precise Eradication of Glioblastoma with a Tumor Site Blood Brain Barrier Permeability Upregulating Nanoparticle

Phototheranostics: Active Targeting of Orthotopic Glioma Using Biomimetic Proteolipid Nanoparticles

NIMG-01. MRI VIRTUAL BIOPSY AND TREATMENT OF PRIMARY OR BRAIN METASTATIC TUMORS WITH TARGETED NANOBIOCONJUGATES

Dual-targeting and Excretable Ultrasmall SPIONs for T1-weighted Positive MR Imaging of Intracranial Glioblastoma Cells by Targeting the Lipoprotein Receptor-Related Protein

Amplified Photoacoustic Imaging of Tumor through In Situ Cycloaddition

Near Infrared-Activatable Biomimetic Nanoplatform for Tumor-Specific Drug Release, Penetration and Chemo-Photothermal Synergistic Therapy of Orthotopic Glioblastoma

Tumor Microenvironment Activated Photoacoustic-Fluorescence Bimodal Nanoprobe for Precise Chemo-immunotherapy and Immune Response Tracing of Glioblastoma

Bioorthogonal Glycoengineering-Mediated Multifunctional Liquid Metal Nanoprobes for Highly Efficient Photoacoustic Imaging-Guided Photothermal/Chemotherapy of Tumor.

Augmented Glioma-Targeted Theranostics Using Multifunctional Polymer-Coated Carbon Nanodots.